Kaufman Bros. Ups Estimates and PT on Quest Diagnostics (DGX) After Share Buyback News
Tweet Send to a Friend
Kaufman Bros. raised estimates and its price target on Buy-rated Quest Diagnostics (NYSE: DGX) from $62 to $64 following news ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
